Search results
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Combo Therapy May Be Advance Against Liver Cancer
KTBS Shreveport· 10 hours agoA new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 4 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
GIBF invests $10 Million in Nectin Therapeutics to Advance Novel Pipeline of First-in-Class...
WTNH-TV New Haven· 9 hours agoGuangzhou-Israel Biotechnology Fund (GIBF) announced today that it has invested $10 million in...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
CG follows big IPO with new results for bladder cancer drug
BioPharma Dive via Yahoo Finance· 3 days agoNewly disclosed Phase 3 results presented Friday match findings the biotech disclosed last year,...
Inside NHS cancer jab trial branded a 'game - who can get it and how it works
Daily Express· 1 day agoScientists have hailed a new personalised cancer vaccine as a “gamechanger” for treating the...
Combo Therapy May Be Advance Against Liver Cancer
US News & World Report· 10 hours agoA new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2 clinical trial. The combo therapy involves ...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 5 days agoUSA News Group – An alarming trend is happening around the world, where tens of millions of...
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 3 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases